Later in the year, GHIT announced another for six partnerships to develop new drugs for malaria and Chagas disease, alongside a vaccine for malaria and diagnostics for tuberculosis. Cumulatively, by the end of 2021, GHIT's total investment in global health R&D since its inception had reached 25.1 billion yen (US$236 million) , with 57 active projects in its portfolio.
Thanks to the swift mobilization, CHISA’s immediate medical expenses were covered, allowing for uninterrupted treatment. While specific long-term outcome data for this particular case remains private, the 2021 campaign was part of a broader national trend where crowdfunding demonstrably changed the landscape of medical financing. That same year, similar campaigns across Indonesia, such as the "Indonesia PASTI BISA" initiative, successfully raised over US$1 million to provide oxygen concentrators during the COVID-19 pandemic. For CHISA, this translated to more than just financial relief; it was a powerful psychological assurance that their university community had their back.
The treatment was successful, allowing Chisas to [mention positive outcome, e.g., return to content creation/make a full recovery]. Lessons in Digital Solidarity
